Amylyx Pharmaceuticals, Inc.

Campbell & CO Investment Adviser LLC AMLX

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/3/2026

Shares

100,963

Value ($000)

1,813

Weight

0.1%

2025 Q3 - 2026 Q2 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/3/2026	1,813	0.1%	100,963	6/30/2026
2026 Q1	5/15/2026	756	0.0%	54,422	3/31/2026
2025 Q4	2/12/2026	951	0.0%	78,763	12/31/2025
2025 Q3	10/28/2025	333	0.0%	24,482	9/30/2025